Developing blood cancer therapies based on highly targeted CAR T cells.
Industry: Health Care
First Day Return: +47.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/07/2018 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 8.8 |
Deal Size ($mm) | $150 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/21/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $150 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | London, United Kingdom |
Founded | 2014 |
Employees at IPO | 126 |
Website www.autolus.com |